Piperno-Neumann S, Carlino MS, Boni V, et al. A phase I trial of LXS196, a PKC inhibitor for uveal melanoma. SMR 2017, abstract SMR09-1.
Pembrolizumab plus mFOLFOX7 of FOLFIRI bij MSS/MMR-proficiënt mCRC
okt 2024 | Immuuntherapie, Maag-darm-leveroncologie